DONGWHA PHARM.CO.,LTD Logo

DONGWHA PHARM.CO.,LTD

Develops, manufactures, and sells a diverse portfolio of healthcare products globally.

000020 | KO

Overview

Corporate Details

ISIN(s):
KR7000020008
LEI:
Country:
South Korea
Address:
서울특별시 중구 서소문로9길 20, 중구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1897, Dongwha Pharm is a pioneering pharmaceutical company with a long history of serving public health. The company is engaged in the research, development, manufacturing, and sale of a diverse portfolio of healthcare products. Its offerings span multiple categories, including prescription pharmaceuticals (ethical drugs), over-the-counter (OTC) medicines, medical devices, quasi-drugs, cosmetics, and health functional foods and beverages. As a fully integrated company, Dongwha Pharm operates its own R&D centers, manufacturing facilities, and a nationwide sales and marketing network. It is committed to innovation, continuously developing new drugs and launching consumer health brands while also exporting its products to global markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.0 MB
2025-08-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.5 KB
2025-07-31 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.2 KB
2025-07-15 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 13.6 KB
2025-06-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 11.2 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 851.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.5 MB
2025-04-30 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.1 KB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 52.2 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.1 KB
2025-03-26 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 31.0 KB
2025-03-26 00:00
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
Korean 6.0 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB
2025-03-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 130.7 KB

Automate Your Workflow. Get a real-time feed of all DONGWHA PHARM.CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGWHA PHARM.CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGWHA PHARM.CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom
HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea
376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland
HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
HERON THERAPEUTICS, INC. /DE/ Logo
Develops and commercializes therapies for acute care and oncology to manage pain and nausea.
United States of America
HRTX
Global manufacturer of carbapenem antibiotic APIs for regulated markets.
South Korea
106190
HIKMA Pharmaceuticals PLC Logo
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
United Kingdom
HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A global leader in transdermal drug delivery systems for OTC and prescription pain relief.
Japan
4530
HLB Genex, Inc. Logo
Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.
South Korea
187420
HLB INC. Logo
A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.
South Korea
028300

Talk to a Data Expert

Have a question? We'll get back to you promptly.